Topical tacrolimus suppresses the expression of vascular endothelial growth factor and insulin-like growth factor-1 in late anagen
β Scribed by Y. Wang; S. Yang; L. Wu; P. Tu
- Book ID
- 108695248
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 486 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0307-6938
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Multiple factors contribute to the growth retardation which is a characteristic feature of uncontrolled diabetes. In this report we have examined the effects of streptozotocin-induced (STZ) diabetes on expression of insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-
Haemangiopericytoma is a rare soft tissue tumour originating from the contractile pericapillary cells. Relatively little is known about its molecular pathogenesis. To address this issue, the insulin-like growth factor family (IGFs) was analysed in 19 tumours collected from a human tumour bank networ
## Abstract ## Background and Methods. VEGF proteins and their receptors are involved in tumor vessel neoformation. The third VEGF receptor, VEGFR3 (fltβ4) is important during both blood vessel development and lymphatic vessel formation. Because HNSCC preferentially metastasizes to regional lymph